Editas Medicine Inc.

NASDAQ: EDIT · Real-Time Price · USD
3.04
0.08 (2.70%)
At close: Aug 15, 2025, 3:59 PM
3.01
-0.99%
After-hours: Aug 15, 2025, 07:52 PM EDT

Editas Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-236.86M -251.23M -237.09M -210.57M -193.45M -166.13M -153.22M -195.08M -205.79M -218.95M -220.43M -201.13M -184.49M -186.29M -192.5M -213.56M -166.66M -134.98M
Depreciation & Amortization
1.55M 1.4M 887K 972K 5.81M 5.93M 6.06M 6.17M 6.26M 6.32M 6.34M 6.27M 5.86M 5.45M 5.05M 4.72M 4.64M 4.32M
Stock-Based Compensation
14.46M 16.81M 21.42M 22.74M 22.67M 22.88M 19.8M 19.82M 20.97M 22.37M 29.29M 31.59M 35.72M 42.63M 43.4M 41.41M 37.25M 29.14M
Other Working Capital
18.4M 17.39M 11.81M 3.05M -88K -727K 4.94M 17.02M 14.19M 21.27M 8.69M -17M -22.17M -27.75M -22.71M -17.14M -90.13M -93.04M
Other Non-Cash Items
9.63M 8.55M 1.05M 16.27M 9.49M 11.01M 13.61M -3.43M -671K -68K -724K 99K 804K 1.49M 1.66M 29.22M 28.8M 28.22M
Deferred Income Tax
n/a n/a n/a -18.64M -16.84M -16.84M -16.84M 1.8M n/a n/a n/a n/a n/a n/a n/a -3.26M -1.84M -9.03M
Change in Working Capital
9.86M 16.27M 3.45M 7.46M 7.68M -3.12M -1.59M 18.52M 14.47M 26.44M 8.18M -6.49M -20.33M -26.83M -21.41M -27.86M -85.53M -92.91M
Operating Cash Flow
-201.36M -208.21M -210.28M -181.76M -164.63M -146.28M -132.18M -152.21M -164.76M -163.89M -177.35M -169.66M -162.44M -163.55M -163.8M -169.32M -183.34M -175.24M
Capital Expenditures
-3.58M -7.07M -8.83M -9.59M -6.91M -4.75M -4.72M -4.04M -4.41M -3.71M -4.12M -6.34M -8.07M -10.14M -7.98M -6.51M -5.96M -5.09M
Cash Acquisitions
n/a n/a n/a -64.15M 38.43M 24.12M -988K -55.01M -247.43M -233.1M -207.99M -43.33M 46.51M 46.49M 46.49M n/a n/a n/a
Purchase of Investments
4K 7K -86.22M -124.97M -276.56M -303.94M -258.52M -325.17M -199.85M -295.6M -315.19M -314.1M -398.28M -341.85M -408.89M -462.61M -586.15M -519.44M
Sales Maturities Of Investments
217.39M 230.34M 257.19M 328.6M 290.69M 276.95M 259.5M 235.1M 302.21M 380.26M 433.35M 439.18M 396.2M 350.65M 362.4M 328.61M 338.98M 340.78M
Other Investing Acitivies
151K n/a n/a 64.15M -38.43M -24.12M 988K 55.01M 247.43M 229.75M 263.26M 98.6M -28.56M -17.69M -72.98M -26.5M 10.82M 3.34M
Investing Cash Flow
213.97M 223.28M 162.15M 194.03M 7.23M -31.74M -3.73M -94.1M 97.95M 80.96M 114.07M 118.76M -10.13M -1.34M -54.47M -140.52M -253.12M -183.74M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
550K 322K 322K 322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.54M -2.87M n/a n/a n/a 117.53M 117.53M 118.14M 118.22M 1.07M 1.28M 1.72M 4.14M 20.85M 32.64M 40.68M 39.01M 29.11M
Financial Cash Flow
61.49M 54.4M 56.03M 1.03M 1.03M 118.23M 118.04M 118.14M 118.22M 1.07M 1.28M 1.72M 4.14M 20.85M 282.11M 290.15M 288.48M 482.55M
Net Cash Flow
74.1M 69.47M 7.89M 13.29M -156.38M -59.79M -17.87M -128.17M 51.42M -81.86M -62M -49.18M -168.43M -144.04M 63.84M -19.69M -147.99M 123.57M
Free Cash Flow
-204.94M -215.28M -219.11M -191.35M -171.54M -151.03M -136.9M -156.25M -169.17M -167.6M -181.47M -176M -170.51M -173.69M -171.78M -175.83M -189.29M -180.33M